J. Arakawa-Hoyt

AAV serotype-1 mediates early onset of gene expression in mouse hearts and results in better therapeutic effect (2006)

Su, H, Huang, Y, Takagawa, J, Barcena, A, Arakawa-Hoyt, J, Ye, J, ...

Adeno-associated viral vectors (AAV) are attractive tool for gene therapy for coronary artery disease. However, gene expression in myocardium mediated by AAV serotype 2 (AAV2) does not peak until 4-6...

Adeno-associated viral vector delivers card iac-specific and hypoxia-inducible VEGF expression in ischemic mouse hearts (2004)

Su, Hua, Joho, S, Huang, Y, Barcena, A, Arakawa-Hoyt, J, Grossman, W, ...

It has been shown that the adeno-associated virus (AAV) vector can deliver the VEGF gene efficiently into the ischemic mouse myocardium. However, the AAV genomes can be found in extracardiac organs...